Advertisement

DNA for the Masses

An Israeli company plans to synthesize DNA on demand for anyone, including those outside of research labs.  

By | October 31, 2012

A model of DNA
Flickr, net_efekt
A new company called Genome Compiler is planning to make DNA synthesis available to anyone via its software that pieces together chunks of DNA chosen by the user. The company would allow synthetic biology enthusiasts to design novel genomes at will.

Although there are many DNA synthesis companies that generate the sequences specifed by an ordering laboratory, Omri Amirav-Drory, the company’s founder and CEO told The Wall Street Journal that “they don’t have the design tools, the combine and debug tools, like you have in [the Genome Compiler] software.” The new program acts like a drag-and-drop puzzle to simplify the process. 

To anyone worried that the venture might result in rogue designers creating deadly or harmful organisms, Amirav-Drory responds that there are checks in place. “You have to start with one of nature’s designs,” he told WSJ. The submitted sequences are also run through the databases of the Centers for Disease Control and Prevention, which will flag those that resemble “bad things,” Amirav-Drory said, such as highly infectious viruses or bacteria. “Every synthesis company is required to send all their orders through this database to check it.”

(Hat tip to GenomeWeb)

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: rosinbio

rosinbio

Posts: 13

November 1, 2012

I see no compelling reason to trust the assumption that anything that does not "resemble" an item in the database of the Center for Disease Contro cannot be "a bad thing".

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Four-legged Snake Fossil Found
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement